NSE: SUNPHARMA
SUN PHARMACEUTICAL IND L
Price history
+4.18% over 3M
Performance
52-week range
Position in day range
SUNPHARMA stock DNA
Signals computed live from NSE price history — trend, momentum, volatility and participation in one view.
Trend
Sideways
50-DMA ₹1,930.43
RSI (14)
42
Neutral momentum
Volatility (ATR)
1.83%
Low
Close streak
6d down
Volume vs 20d avg
0.97x
From 52W high
-10.11%
Up from 52W low
+18.86%
Green days (20)
6/20
Monthly seasonality
Average monthly move for SUNPHARMA across the available price history.
Key statistics
Open
1,845
Day high
1,854.5
Day low
1,834
Prev close
1,840
Volume
14.45 L
Avg vol (20d)
14.89 L
52W high
2,046.9
52W low
1,548
SUNPHARMA quarterly results
All SUNPHARMA results →Next results date
Awaiting intimation
Last results date
—
Reports published
Coverage coming soon
Revenue
₹15,184 cr
+10.1% YoY
Net profit
₹2,895 cr
+27.0% YoY
Operating profit
₹3,557 cr
+5.5% YoY
EPS
₹12.10
+27.4% YoY
| Quarter | Revenue | Operating profit | Net profit | OPM | Net margin | EPS | Profit YoY | Profit QoQ |
|---|---|---|---|---|---|---|---|---|
| Q1 FY272026-06-30 | ₹15,184 cr | ₹3,557 cr | ₹2,895 cr | 23.4% | 19.1% | ₹12.10 | +27.0% | +6.7% |
| Q4 FY262026-03-31 | ₹14,560 cr | ₹2,752 cr | ₹2,714 cr | 18.9% | 18.6% | ₹11.30 | +26.2% | -19.4% |
| Q3 FY262025-12-31 | ₹15,469 cr | ₹4,062 cr | ₹3,369 cr | 26.3% | 21.8% | ₹14.00 | — | +47.8% |
| Q1 FY262025-06-30 | ₹13,786 cr | ₹3,372 cr | ₹2,279 cr | 24.5% | 16.5% | ₹9.50 | — | +6.0% |
| Q4 FY252025-03-31 | ₹12,816 cr | ₹2,761 cr | ₹2,150 cr | 21.5% | 16.8% | ₹9.00 | — | — |
| TTM (last 4 quarters) | ₹58,998 cr | ₹13,743 cr | ₹11,256 cr | 23.3% | 19.1% | ₹46.90 | — | — |
Consolidated figures as reported to the exchanges, shown in ₹ crore. OPM = operating profit margin. Updated automatically whenever a new quarter is filed.
Latest coverage
No stories tagged with SUNPHARMA yet — see the latest from the markets desk below.
Latest market news
Morning Market Buzz, 12 September 2026: IPOs Tops the Coverage Ahead of Policy And Macro Data and Banks And NBFCs
The most-covered market themes in the morning session on 12 September 2026 — IPOs, policy and macro data, banks and NBFCs — with our live numbers for each and links to the publishers running the story.
Raymond Share Price Hits 52-Week High, Up 14.85%: What Is Driving RAYMOND Today, and the Levels That Matter
Raymond (RAYMOND) trades at ₹1,002.80, +148.95 (+14.85%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
HDFC AMC Edges Lower to ₹2,403.90 — Should Investors Read This as a Trend or a One-Day Move?
HDFC AMC (HDFCAMC) trades at ₹2,403.90, -29.90 (-1.24%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Granules India Hits 52-Week High, Up 1.11% — Should Investors Read This as a Trend or a One-Day Move?
Granules India (GRANULES) trades at ₹909.30, +10.05 (+1.11%). The in-focus trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Gujarat Fluorochem Share Price Trades Flat at ₹4,773.20: What Is Driving FLUOROCHEM Today, and the Levels That Matter
Gujarat Fluorochem (FLUOROCHEM) trades at ₹4,773.20, -13.10 (-0.27%). We read the exchange board, the volume against its own average, and what a shareholder should actually do with this information.
Canara Hsbc Life Ins Share Price Trades Flat at ₹151.92 on Regulatory News — What It Means for Investors
Canara Hsbc Life Ins (CANHLIFE) trades at ₹151.92, -0.44 (-0.29%). The regulatory trigger, the levels the tape is defending, and what the numbers mean for traders and long-term holders.
Price and history data from NSE via Upstox. For information only, not investment advice.